Key points are not available for this paper at this time.
Rituximab dose selection based on macrophage phagocytosis in CD20-positive NHL cell lines. Data showed that a rituximab dose of 0.1 nM induced maximal phagocytosis in OCI-Ly3 cells.
Chan et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: